Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "PL Lodz Watala C"

From Bioblast
Line 1: Line 1:
{{MiPNetLab
{{MiPNetLab
|address=Watala Cezary
|address=[[Watala C|Watala Cezary]], Prof. Dr.


Department of Haemostasis
Department of Haemostasis and Haemostatic Disorders
and Haemostatic Disorders


Medical University of Lodz
Medical University of Lodz
Line 9: Line 8:
113 Zeromskiego Street
113 Zeromskiego Street


90-549 Łódź   POLAND
90-549 Łódź, POLAND
|city=Lodz
|city=Lodz
|country=Poland
|country=Poland
|MiPNetLab=Watala C, Labieniec M
|MiPNetLab=Watala C, Labieniec M
|info=[[IOC61]], [http://www.oroboros.at/index.php?id=ioc55-56 IOC55-56]
|info=[http://www.oroboros.at/?IOC55-56 IOC55-56], [[IOC61]]
}}
}}
*Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
*Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
*Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
*Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
*targeting of biochemical and molecular burden of diabetes
*targeting of biochemical and molecular burden of diabetes

Revision as of 13:11, 3 June 2012

Template:MiPNetLab

  • Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
  • Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
  • targeting of biochemical and molecular burden of diabetes